Common Stock, Shares, Outstanding of Poseida Therapeutics, Inc. from 31 Dec 2019 to 30 Sep 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Poseida Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2019 to 30 Sep 2024.
  • Poseida Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2024 was 97,411,571, a 1.9% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Poseida Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2024 97,411,571 +1,838,045 +1.9% 30 Sep 2024 10-Q 07 Nov 2024 2024 Q3
Q2 2024 97,080,817 +10,202,476 +12% 30 Jun 2024 10-Q 05 Aug 2024 2024 Q2
Q1 2024 96,798,009 +10,039,122 +12% 31 Mar 2024 10-Q 14 May 2024 2024 Q1
Q4 2023 95,636,553 +9,672,392 +11% 31 Dec 2023 10-Q 07 Nov 2024 2024 Q3
Q3 2023 95,573,526 +9,627,112 +11% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 86,878,341 +24,149,615 +38% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 86,758,887 +24,054,161 +38% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 85,964,161 +23,440,565 +37% 31 Dec 2022 10-K 07 Mar 2024 2023 FY
Q3 2022 85,946,414 +23,476,595 +38% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 62,728,726 +562,559 +0.9% 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 62,704,726 +577,990 +0.93% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 62,523,596 +662,699 +1.1% 31 Dec 2021 10-K 09 Mar 2023 2022 FY
Q3 2021 62,469,819 +650,310 +1.1% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 62,166,167 +48,795,389 +365% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 62,126,736 31 Mar 2021 10-Q 11 May 2021 2021 Q1
Q4 2020 61,860,897 +48,664,478 +369% 31 Dec 2020 10-K 10 Mar 2022 2021 FY
Q3 2020 61,819,509 30 Sep 2020 10-Q 12 Nov 2020 2020 Q3
Q2 2020 13,370,778 30 Jun 2020 10-Q 20 Aug 2020 2020 Q2
Q4 2019 13,196,419 31 Dec 2019 10-K 11 Mar 2021 2020 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.